Skip to content
★ Sign in to follow
MP

Maxim Pharmaceuticals Inc Stock: price and insider trades · United States

Maxim Pharmaceuticals Inc: what insiders have been doing

We have very little insider data for Maxim Pharmaceuticals Inc so far: the most recent filing dates from 6 January 2006. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 6 January 2006
Declarations6 total
  • ●
    DirectorExecutives
    0SEC
    71,228 sharesCommon StockSEC:0001104659-06-001043:0
  • ●
    DirectorExecutives
    0SEC
    790 sharesCommon StockSEC:0001104659-06-001043:1
  • ●
    DirectorExecutives
    0SEC
    333 sharesCommon StockSEC:0001104659-06-001045:0
  • ●
    Chief Financial OfficerExecutives
    0SEC
    4,042 sharesCommon StockSEC:0001104659-06-001044:0
  • ●
    Chairman,CEO and PresidentExecutives
    0SEC
    3,657 sharesCommon StockSEC:0001104659-06-001042:0
  • ●
    Chairman,CEO and PresidentExecutives
    0SEC
    10,000 sharesCommon StockSEC:0001104659-06-001042:1

6 of 6 declarations

About Maxim Pharmaceuticals Inc

Maxim Pharmaceuticals Inc is a company focused on developing innovative pharmaceutical treatments. It is listed on NASDAQ under the ticker XNAS.